- funded by IMI-JU
- 01 March 2011 - 31 August 2016
- 11 EFPIA members
- 10 Academia and 5 SME's
- Total cost € 23,032,609
The Servier Group is the leading French independent pharmaceutical company. Servier is established in 140 countries, the worldwide workforce of the Group is over 20,000 people. The Group has developed recognised medicines against major human diseases . Within the Group, the companies Institut de Recherches Servier and Technologie Servier are in charge of the Research and Development.
Servier has an extensive experience of developing drugs in several therapeutic areas, such as cardiovascular, diabetes, CNS, oncology etc; It was an early adopter of population PK and PK/PD modeling and simulation techniques . Modeling and simulation has been successfully applied to many different projects and results have been integrated in several NDAs.